The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.

Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team found that removing an enzyme from neurons in the brain substantially reduces ...

Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the key to stopping the condition in its tracks. It is well established that ...

Here’s what you’ll learn when you read this story: Treating Alzheimer’s requires a multi-faceted approach that can target various mechanisms behind this pernicious neurodegenerative disease. In a new ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A scientist looks at hypometabolic and hypoperfusion patterns at the single-subject level from a patient suffering ...

Scientists have developed a blood test that could predict Alzheimer's symptoms years in advance using p-tau217 protein levels ...

A bill introduced in the Nebraska Legislature would require insurers to cover FDA-approved Alzheimer's drugs for the 35,000+ ...

Fri, Feb 13, 2026 A groundbreaking study has discovered that a widely-used medication could help prevent Alzheimer's symptoms ...

A new study study finds that brain swelling (ARIA-E) from Alzheimer's drugs identifies the regions where amyloid plaques are being cleared most effectively.

Antihypertensives that stimulate angiotensin II receptors are associated with a lower risk for biomarkers of dementia.

Experts see shift toward tailored cancer therapy model Lilly awaiting details of Novo's failed trial Some drug developers target multiple biomarkers Sign up here. Globally, over 55 million people have ...